You're exactly right. Which is why there is NO NEW DISCLOSURE OF AN AGREEMENT. Exactly what I have been saying.
You seem not to understand that though. Because you go on to say there is no agreement with COGNATE in place. This is false. There is an agreement that provides, as was ORIGINALLY INTENDED, that it expires when they are approved and 5 years pass, and no other agreement is put into place. At that time, they will decide the terms of commercial production with Cognate, as per their disclosure documents, if any, and where. They can't make those decisions now.
But to say NO agreement exists, is patently false. Additionally, they signed another NEW Agreement with Cognate in 2019, for DCVax Direct.
I have pointed out previously, there is no Commercial Manufacturing Agreement, but as always intended, the EXISTING agreement provides for WHEN that agreement will be put into place.
This agreement never ended, and should they want to fund a new trial, they have this agreement in place.
The notion that there is no agreement and CRL and COGNATE are irrelevant because no agreement has ever been posted on the SEC database is a fake argument.
That was never the agreement structure.
I am not trying to overcomplicate, that is up to you and the others requiring that something that should be done has not been done when that is false.
I do not think you don't understand. It is imperative to a certain segment to suggest that there is no ongoing relationship with Cognate and that is just not true. And the production agreement to make DCVax Direct, signed in 2019, which also continues, is proof that those who want to suggest there is nothing there and if it did exist it would have to be reposted in the SEC database, are just wrong.
No termination occurred, no ending of the relationship. These companies still have the opportunity to do whatever they would like to do in the future, but the better deal is usually doing as much as you can for yourself first, which appears to be what NWBO is in the process of doing.
Sorry you don't win this argument.
